SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 53.47+0.3%Nov 28 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (3083)3/14/2001 8:08:11 PM
From: Biomaven  Read Replies (2) of 52153
 
<ALXN>

the company only uses 16.661 million shares in their computations

This is because the offering happened only part way through that reporting period. 18 million shares is the number now outstanding, without taking into account any dilution from options.

Note that a diluted number only gets reported once the company is profitable on an operating basis. It is possible to estimate the diluted number before then based on a 10-K, as the options outstanding are then shown broken down by price range. (It's in the FAS 123 footnote). In ALXN's case, based on their last 10-K, I would estimate that there would be a little over an additional 1 million shares outstanding on a diluted basis.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News